Finance

Lists
1GEHC:BIT
GE HealthCare Technologies Inc
€64.15
+0.30%
(+0.19) 1D
Aug 24, 5:26:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1GEHC...
Open
€63.31
High
€64.45
Low
€63.31
Mkt. cap
33.55B
Avg. vol.
75.00
Volume
67.00
52-wk high
€74.43
52-wk low
€50.80
No. of employees
54K
Open
€63.31
High
€64.45
Low
€63.31
Mkt. cap
33.55B
Avg. vol.
75.00
Volume
67.00
52-wk high
€74.43
52-wk low
€50.80
No. of employees
54K
News stories
From web sources and news partners
Profile
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals. GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition. GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Wikipedia
About GE HealthCare Technologies Inc
CEOPeter J Arduini
Employees54K
Founded1994
HeadquartersChicago, Illinois, United States
SectorMedical device
Websitegehealthcare.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.14B
5.70B
5.13B
5.30B
Cost of goods sold
3.15B
3.44B
3.15B
3.12B
Cost of revenue
3.15B
3.44B
3.15B
3.12B
Research and development expenses
292.00M
323.00M
345.00M
323.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
966.00M
1.04B
1.06B
1.06B
Operating expense
1.26B
1.36B
1.41B
1.39B
Total operating expenses
4.41B
4.80B
4.56B
4.50B
Operating income
731.00M
896.00M
569.00M
793.00M
Other non operating income
11.00M
4.00M
36.00M
7.00M
EBT including unusual items
643.00M
821.00M
505.00M
693.00M
EBT excluding unusual items
643.00M
821.00M
505.00M
693.00M
Income tax expense
179.00M
219.00M
94.00M
119.00M
Effective tax rate
27.84%
26.67%
18.61%
17.17%
Other operating expenses
-
-
-
-
Net income
446.00M
589.00M
389.00M
561.00M
Net profit margin
8.67%
10.34%
7.58%
10.59%
Earnings per share
1.07
1.44
0.99
1.13
Interest and investment income
12.00M
24.00M
-
7.00M
Interest expense
-128.00M
-6.00M
-115.00M
-133.00M
Net interest expenses
-116.00M
18.00M
-115.00M
-126.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
879.00M
1.04B
722.00M
953.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps